Stockholders’ Equity - Schedule of Warrant Activities (Details) - Warrant [Member] - USD ($) |
6 Months Ended | |
|---|---|---|
Dec. 31, 2025 |
Jun. 30, 2026 |
|
| Schedule of Warrant Activities [Line Items] | ||
| Number of Warrants, Granted | ||
| Weighted Average Exercise Price, Granted | ||
| Aggregate Intrinsic Value, Granted | ||
| Number of Warrants, Exercised | (18,689) | |
| Weighted Average Exercise Price, Exercised | $ 231.29 | |
| Aggregate Intrinsic Value, Exercised | ||
| Number of Warrants, Ending Balance | 682,670 | 663,981 |
| Weighted Average Exercise Price, Ending Balance | $ 21.22 | $ 15.31 |
| Weighted Average Remaining Contractual Term (Years), Ending Balance | 3 years 4 months 24 days | 3 years |
| Aggregate Intrinsic Value, Ending Balance | ||
| Number of Warrants, Exercisable | 663,981 | |
| Weighted Average Exercise Price, Exercisable | $ 15.31 | |
| Weighted Average Remaining Contractual Term (Years), Exercisable | 3 years | |
| Aggregate Intrinsic Value, Exercisable |
| X | ||||||||||
- Definition The number of exercised made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). No definition available.
|
| X | ||||||||||
- Definition he number of exercisable made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). No definition available.
|
| X | ||||||||||
- Definition The weighted average outstanding exercise price. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price, exercised. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price granted. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price, exercisable. No definition available.
|
| X | ||||||||||
- Definition Intrinsic value of exercisable award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Definition Aggregate intrinsic value, exercised. No definition available.
|
| X | ||||||||||
- Definition Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted-average contractual term remaining for equity-based award excluding option, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|